Isotype-specific functions of Raf kinases

Experimental Cell Research

Volumn 253, Issue 1, 1999, Pages 34-46

  Hagemann, Carsten ^a   Rapp, Ulf R ^a  

^a Inst Med Strahlenkunde Z   (Germany)

Author keywords

Interaction partner; Raf; Signal transduction; Specificity

Indexed keywords

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENTEROPATHY; ENZYME ACTIVITY; GROWTH RETARDATION; KNOCKOUT MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033604576     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4689     Document Type: Article

References (113)

1. Aitken A. 14-3-3 and its possible role in co-ordinating multiple signalling pathways. Trends Cell Biol. 6:1996;341-347.
2. Allende J. E., Allende C. C. Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation. FASEB J. 9:1995;313-323.
3. Barnier J. V., Papin C., Eychene A., Lecoq O., Calothy G. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J. Biol. Chem. 270:1995;23381-23389.
4. Blenis J. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc. Natl. Acad. Sci. USA. 90:1993;5889-5892.
5. Bogoyevitch M. A., Marshall C. J., Sugden P. H. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes. J. Biol. Chem. 270:1995;26303-26310.
6. Boldyreff B., Issinger O.-G. A-Raf kinase is a new interacting partner of protein kinase CK2β subunit. FEBS Lett. 403:1997;197-199.
7. Boldyreff B., Mietens U., Issinger O.-G. Structure of protein kinase CK2: Dimerization of the human β-subunit. FEBS Lett. 379:1996;153-156.
8. Braselmann S., McCormick F. Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J. 14:1995;4839-4848.
9. Brinck U., Eigenbrodt E., Oehmke M., Mazurek S., Fischer G. L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases. Virchow's Arch. 424:1994;177-185.
10. Catling A. D., Reuter C. W., Cox M. E., Parsons S. J., Weber M. J. Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf associated activity. J. Biol. Chem. 269:1994;30014-30021.
11. Chantalat L., Leroy D., Filhol O., Nueda A., Benitez M. J., Chambaz E. M., Cochet C., Dideberg O. Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization. EMBO J. 18:1999;2930-2940.
12. Chen M., Cooper J. A. The β subunit of CKII negatively regulates Xenopus oocyte maturation. Proc. Natl. Acad. Sci. USA. 94:1997;9136-9140.
13. Chen M., Li D., Krebs E. G., Cooper J. A. The casein kinase IIβ subunit binds to Mos and inhibits Mos activity. Mol. Cell. Biol. 17:1997;1904-1912.
14. Chien K. R., Knowlton K. U., Zhu H., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J. 5:1991;3037-3046.
15. Conklin D. S., Galaktionov K., Beach D. 14-3-3 proteins associate with cdc25 phosphatases. Proc. Natl. Acad. Sci. USA. 92:1995;7892-7896.
16. Cook J. G., Bardwell L., Thorner J. Inhibitory and activating function for MAPK Kss1 in the S. cerevisiae filamentous-growth signalling pathway. Nature. 390:1997;85-88.
17. Daum G., Eisenmann-Tappe I., Fries H.-W., Troppmair J., Rapp U. R. Ins and outs of Raf kinases. Trends Biochem. Sci. 19:1994;474-480.
18. Denouel Galy A., Douville E. M., Warne P. H., Papin C., Laugier D., Calothy G., Downward J., Eychene A. Musine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr. Biol. 8:1998;46-55.
19. Dick T. P., Ruppert T., Groettrup M., Kloetzel P. M., Kuehn L., Koszinowski U. H., Stevanovic S., Schild H., Rammensee H.-G. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell. 86:1996;253-262.
20. Drexler H. C. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA. 94:1997;855-860.
21. Drexler H. C. A. Programmed cell death and the proteasome. Apoptosis. 3:1998;1-7.
22. Dugan L. L., Kim J. S., Zhang Y., Bart R. D., Sun Y., Holtzman D. M., Gutmann D. H. Differential effects of cAMP in neurons and astrocytes. J. Biol. Chem. 274:1999;25842-25848.
23. Eigenbrodt E., Reinacher M., Scheefers-Borchel U., Scheefers H., Friis R. R. Double role for pyruvate kinase type M2 in the expression of phosphometabolite pools found in tumor cells. Perucho M. Critical Reviews in Oncogenesis. 1992;3 CRC Press, Boca Raton.
24. Erhardt P., Schremser E. J., Cooper G. M. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 19:1999;5308-5315.
25. Erhardt P., Troppmair J., Rapp U. R., Cooper G. M. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol. Cell. Biol. 15:1995;5524-5530.
26. Fantl W. J., Muslin A. J., Kikuchi A., Martin J. A., Mac Nicol A. M., Gross R. W., Williams L. T. Activation of Raf-1 by 14-3-3 proteins. Nature. 371:1994;612-614.
27. Farrar M., Alberola-Ila J., Perlmutter R. M. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature. 383:1996;178-181.
28. Freed E., Symons M., Macdonald S. G., McCormick F., Ruggieri R. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science. 265:1994;1713-1716.
29. Gajewski T. F., Thompson C. B. Apoptosis meets signal transduction: Elimination of a BAD influence. Cell. 87:1996;589-592.
30. Galactionov K., Jessus C., Beach D. Raf-1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev. 9:1995;1046-1058.
31. Garrington T. P., Johnson G. L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:1999;211-218.
32. Graham S. M., Oldham S. M., Martin C. B., Drugan J. K., Zohn I. E., Campbell S., Der C. J. TC21 and Ras share indistinguishable transforming and differentiating activities. Oncogene. 18:1999;2107-2116.
33. Grimm L., Goldberg A. L., Poirier G. G., Schwartz L. M., Osborne B. A. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15:1996;3835-3844.
34. Groettrup M., Soza A., Eggers M., Kuehn L., Dick T. P., Schild H., Rammensee H.-G., Koszinowski U. H., Kloetzel P.-M. A role for the proteasome regulator PA28α in antigen presentation. Nature. 381:1996;166-168.
35. Hagemann C., Kalmes A., Wixler V., Wixler L., Schuster T., Rapp U. R. The regulatory subunit of protein kinase CK2 is a specific A-Raf activator. FEBS Lett. 403:1997;200-202.
36. Heriche J.-K., Lebrin F., Rabilloud T., Leroy D., Chambaz E. M., Goldberg Y. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2α Science. 276:1997;952-955.
37. Herskowith I. MAP kinase pathways in yeast for mating and more. Cell. 80:1995;187-197.
38. Hu C.-D., Kariya K.-I., Kotani G., Shirouzu M., Yokoyama S., Kataoka T. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with Ras-dependent activation of Raf-1. J. Biol. Chem. 272:1997;11702-11705.
39. Irie K., Gotoh Y., Yashar B. M., Errede B., Nishida E., Matsumoto K. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science. 265:1994;1716-1719.
40. Issinger O.-G. Casein kinases: Pleiotropic mediators of cellular regulation. Pharmacol. Ther. 59:1993;1-30.
41. Jaiswal R., Weissinger E., Kolch W., Landreth G. E. Nerve growth factor-mediated activation of the mitogen-activated protein (MAP) kinase cascade involves a signaling complex containing B-Raf and HSP90. J. Biol. Chem. 271:1996;23626-23629.
42. Jelinek T., Catling A. D., Reuter C. W. M., Moodie S. A., Wolfman A., Weber M. J. Ras and Raf-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell. Biol. 14:1994;8212-8218.
43. Jelinek T., Dent P., Sturgill T. W., Weber M. J. Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol. Cell. Biol. 16:1996;1027-1034.
44. Kalmes A., Hagemann C., Weber C. K., Wixler L., Schuster T., Rapp U. R. Interaction between the protein kinase B-Raf and the α-subunit of the 11S proteasome regulator. Cancer Res. 58:1998;2986-2990.
45. Kitayama H., Sugimoto Y., Matsuzaki T., Ikava Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 56:1989;77-84.
46. Kroemer G. The proto-oncogene Bcl2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620.
47. Kuroda S., Ohtsuka T., Yamamori B., Fukui K., Shimuzu K., Takai Y. Different effects of various phospholipids on Ki-Ras-, Ha-Ras, and Rap1B-induced B-Raf activation. J. Biol. Chem. 271:1996;14680-14683.
48. Lebrin F., Bianchini L., Rabilloud T., Chambaz E. M., Goldberg Y. CK2α-protein phosphatase 2A molecular complex: Possible interaction with the MAP kinase pathway. Mol. Cell. Biochem. 191:1999;207-212.
49. Li S., Janosch P., Tanji M., Rosenfeld G. C., Waynire J. C., Mischak H., Kolch W., Sedvy J. M. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. EMBO J. 14:1995;685-696.
50. Lopes U. G., Erhardt P., Yao R., Cooper G. M. P53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272:1997;12893-12896.
51. Lüscher B., Litchfield D. W. Biosynthesis of casein kinase II in lymphoid cell lines. Eur. J. Biochem. 220:1994;521-526.
52. Luo Z., Tzivion G., Belshaw P. J., Vavvas D., Marshall M., Avruch J. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism. Nature. 383:1996;181-185.
53. MacNicol M. C., MacNicol A. M. Nerve growth factor stimulated B-Raf catalytic activity is refractory to inhibition by cAMP-dependent protein kinase. J. Biol. Chem. 274:1999;13193-13197.
54. Madhani H. D., Styles C. A., Fink G. R. MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation. Cell. 91:1997;673-684.
55. Marais R., Light Y., Paterson H. F., Mason C. S., Marshall C. J. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic Ras and tyrosine kinases. J. Biol. Chem. 272:1997;4378-4383.
56. Mason C. S., Springer C. J., Cooper R. G., Superti-Furga G., Marshall C. J., Marais R. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18:1999;2137-2148.
57. McCubrey J. A., Steelman L. S., Hoyle P. E., Blalock W. L., Weinstein-Oppenheimer C., Franklin R. A., Cherwinski H., Bosch E., McMahon M. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia. 12:1998;1903-1929.
58. Meggio F., Boldyreff B., Marin O., Pinna L. A., Issinger O.-G. Role of the β subunit of casein kinase 2 on the stability and specificity of the recombinant reconstituted holoenzyme. Eur. J. Biochem. 204:1992;293-297.
59. Morrison D. K., Cutler R. E. Jr. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9:1997;174-179.
60. Muszynski K. W., Ruscetti F. W., Heidecker G., Rapp U., Troppmair J., Gooya J. M., Keller J. R. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells. J. Exp. Med. 181:1995;2189-2199.
61. Naumann U., Hoffmeyer A., Flory E., Rapp U. R. Raf protein serine/threonine kinases. Protein Phosphorylation. 1996;VCH, Weinheim.
62. Ohtsuka T., Shimizu K., Yamamori B., Kuroda S., Takai Y. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. J. Biol. Chem. 271:1996;1258-1261.
63. Papin C., Denouel A., Calothy G., Eychene A. Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. Oncogene. 12:1996;2213-2221.
64. Papin C., Denouel-Galy A., Langier D., Calothy G., Eychene A. Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J. Biol. Chem. 273:1998;24939-24947.
65. Petosa C., Masters S. C., Bankston L. A., Pohl J., Wang B., Fu H., Liddington R. C. 14-3-3ζ binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J. Biol. Chem. 273:1998;16305-16310.
66. Pritchard C. A., Bolin L., Lattery R., Murray R., McMahon M. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr. Biol. 6:1996;614-617.
67. Pritchard C. A., Samuels M. L., Bosch E., McMahon M. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:1995;6430-6442.
68. Reuter C. W. M., Catling A. D., Jelinek T., Weber M. J. Biochemical analysis of MEK activation in NIH 3T3 fibroblasts. Identification of B-Raf and other activators. J. Biol. Chem. 270:1995;7644-7655.
69. Rommel C., Radziwill G., Lovric J., Noeldeke J., Heinicke T., Jones D., Aitken A., Moelling K. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene. 12:1996;609-619.
70. Rosario M., Paterson H. F., Marshall C. J. Activation of Raf/MAP kinase cascade by the Ras related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J. 18:1999;1270-1279.
71. Roy S., McPherson R. A., Apolloni A., Yan J., Lane A., Clyde-Smith J., Hancock J. F. 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol. Cell. Biol. 18:1998;3947-3955.
72. Sadoul R., Fernandez P. A., Quiquerez A.-L., Martinou I., Maki M., Schröter M., Becherer J. D., Irmler M., Tschopp J., Martinou J.-C. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15:1996;3845-3852.
73. Sakoda T., Kaibuchi K., Kishi K., Kishida S., Doi K., Hoshino M., Hattori S., Takai Y. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH 3T3 cells. Oncogene. 7:1992;1705-1711.
74. Schaeffer H. J., Catling A. D., Eblen S. T., Collier L. S., Krauss A., Weber M. J. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science. 281:1998;1668-1671.
75. Schramm K., Niehof M., Radziwill G., Rommel C., Moelling K. Phosphorylation of c-Raf-1 by protein kinase A interferes with activation. Biochem. Biophys. Res. Commun. 201:1994;740-747.
76. Seliger B., Maeurer M. J., Ferrone S. TAP off - Tumors on. Immunol. Today. 18:1997;292-299.
77. Shinkai M., Masuda T., Kariya K., Tamada M., Shirouzu M., Yokoyama S., Kataoka T. Difference in the mechanism of interaction of Raf-1 and B-Raf with H-Ras. Biochem. Biophys. Res. Commun. 223:1996;729-734.
78. Slupsky J. R., Weber C. K., Ludwig S., Rapp U. R. Raf-dependent signaling pathways in cell growth and differentiation. Bannasch P., Kondac D., Papa S., Tager J. M. Cell Growth and Oncogenesis. 1998;Birkhäuser, Basel.
79. Staal G. E. J., Rijksen G. Pyruvate kinase in selected human tumors. Pretlow T. G., Pretlow T. P. Biochemical and Molecular Aspects of Selected Cancers. 1991;Academic Press, San Diego.
80. Stalter G., Siemer S., Becht E., Ziegler M., Remberger K., Issinger O.-G. Symmetric expression of protein kinase CK2 subunits in human kidney tumors. Biochem. Biophys. Res. Commun. 202:1994;141-147.
81. Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K. L. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol. Cell. Biol. 19:1999;5523-5534.
82. Stigare J., Buddelmeijer N., Pigon A., Egyhazi E. A majority of casein kinase IIα subunits is tightly bound to intranuclear components but not to the β-subunit. Mol. Cell. Biochem. 129:1993;77-85.
83. Suean K.-L., Bustelo X. R., Barbacid M. Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells. Oncogene. 11:1995;825-831.
84. Sutor S. L., Vroman B. T., Armstrong E. A., Abraham R. T., Karnitz L. M. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf. J. Biol. Chem. 274:1999;7002-7010.
85. Therrien M., Wong A. M., Rubin G. M. CNK, a Raf-binding multidomain protein required for Ras signaling. Cell. 95:1998;343-353.
86. Traverse S., Cohen P. Identification of a latent MAP kinase kinase kinase in PC12 cells as B-Raf. FEBS Lett. 350:1994;13-18.
87. Troppmair J., Bruder J. T., Munoz H., Lloyd P. A., Kyriakis J., Banerjee P., Avruch J., Rapp U. R. Mitogen-activated protein kinase/extracellular signal regulated protein kinase activation by oncogenes, serum and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem. 269:1994;7030-7035.
88. Troppmair, J, and, Rapp, U. R. 1997, Apoptosis regulation by Raf, Bcl2, and R-Ras, In, Results in Cancer Research, Vol, 143, Risk and Progression Factors in Carcinogenesis, (, H. K. Müller-Hermelink, H. G. Neumann, and W. Dekant, Eds.), Springer-Verlag, Berlin, Heidelberg.
89. Tzivion G., Luo Z., Avruch J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature. 394:1998;88-92.
90. Vincenz C., Dixit V. M. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J. Biol. Chem. 271:1996;20029-20034.
91. Voice J. K., Klenke R. L., Le A., Jackson J. H. Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274:1999;17164-17170.
92. Vossler M. R., Yao H., York R. D., Pan M.-G., Rim C. S., Stark P. J. S. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
93. Wang H. G., Rapp U. R., Reed J. C. Bcl2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;1-20.
94. Wang H. G., Reed J. C. Bcl2, Raf-1 and mitochondrial regulation of apoptosis. Biofactors. 8:1998;13-16.
95. Wang H.-G., Takayama S., Rapp U. R., Reed J. C. Bcl-2 interacting protein, Bag-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA. 93:1996;7063-7068.
96. Weber, C. K, Slupsky, J. R, Herrmann, C, Schuler, M, Rapp, U. R, and, Block, C. 1999, Differential interaction of Ras and Raf isozymes: Implications for downstream signalling. Submitted for publication.
97. Whitmarsh A. J., Cavanagh J., Tournier C., Yasuda J., Davis R. J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
98. Wittinghofer A., Nassar N. How Ras-related proteins talk to their effectors. Trends Biochem. Sci. 21:1996;488-491.
99. Wixler V., Smola U., Schuler M., Rapp U. Differential regulation of Raf isozymes versus differentiation inducing factors in PC12 pheochromocytoma cells. FEBS Lett. 385:1996;131-137.
100. Wojnowski, L, Stancato, L. F, Larner, A. C, Rapp, U. R, and, Zimmer, A. 1999, Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Submitted for publication.
101. Wojnowski L., Stancato L. F., Zimmer A. M., Hahn H., Beck T. W., Larner A. C., Rapp U. R., Zimmer A. Craf-1 protein kinase is essential for mouse development. Mech. Dev. 76:1998;141-149.
102. Wojnowski L., Zimmer A. M., Beck T. W., Hahn H., Bernal R., Rapp U. R., Zimmer A. Endothelial apoptosis in Braf-deficient mice. Nat. Genet. 16:1997;293-297.
103. Wu J., Dent P., Jelinek T., Wolfman A., Weber M. J., Sturgill T. W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 262:1993;1065-1069.
104. Wu J., Harrison J. K., Dent P., Lynch K. R., Weber M. J., Sturgill T. W. Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol. Cell. Biol. 13:1993;4539-4548.
105. Wu X., Noh S. J., Zhou G., Dixon J. E., Guan K. L. Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated HeLa cells. J. Biol. Chem. 271:1996;3265-3271.
106. Xing H., Kornfeld K., Muslin A. J. The protein kinase KSR interacts with 14-3-3 protein and Raf. Curr. Biol. 7:1997;294-300.
107. Xu S., Khoo S., Dang A., Witt S., Do V., Zhen E., Schaefer E. M., Cobb M. H. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism. Mol. Endocrinol. 11:1997;1618-1625.
108. Yamamori B., Kuroda S., Shimizu K., Fukui K., Ohtsuka T., Takai Y. Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J. Biol. Chem. 270:1996;11723-11726.
109. Yan J., Roy S., Apolloni A., Lane A., Hancock J. F. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273:1998;24052-24056.
110. York R. D., Yao H., Dillon T., Ellig C. L., Eckert S. P., McCleskey E. W., Stork P. J. S. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622-626.
111. L. Cell. 87:1996;619-628.
112. Zhang Z., Clawson A., Realini C., Jensen C. C., Knowlton J. R., Hill C. P., Rechsteiner M. Identification of an activator region in the proteasome activator REGα Proc. Natl. Acad. Sci. USA. 96:1998;2807-2811.
113. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 364:1993;308-313.